Table 1.
Astaxanthin intended (mg/kg bw) | 0 (control) | 0 (Placebo) | 125 | 250 | 500 | 1,000 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
M | F | M | F | M | F | M | F | M | F | M | F | |
Yellow‐brown pigmentation hepatocytes | 0 | 3 | 0 | 2 | 1 | 23 | 2 | 25 | 10 | 26 | 10 | 23 |
Yellow‐brown pigmentation macrophages | 0 | 3 | 1 | 2 | 0 | 16 | 0 | 20 | 4 | 24 | 2 | 22 |
Hepatocellular hypertrophy | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 7 | 0 | 11 | 0 | 13 |
Inflammatory foci | 3 | 4 | 9 | 9 | 4 | 3 | 4 | 4 | 3 | 7 | 5 | 11 |
Vacuolation1 | 9 | 12 | 8 | 11 | 10 | 6 | 11 | 15 | 6 | 14 | 12 | 11 |
Multinucleated cells/cytomegalic hepatocytes | 0 | 2 | 0 | 2 | 0 | 4 | 0 | 4 | 0 | 5 | 0 | 7 |
Periportal, diffuse and centrilobular hepatocytes.